Myriad Genetics Executive and Leadership Team

Benjamin Wheeler, the Chief Financial Officer at Myriad Genetics, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures robust investment in molecular diagnostic research and development. This leadership role involves managing investor relations and maintaining fiscal transparency across North American operations. By optimizing the capital structure, Benjamin Wheeler directly impacts the ability of the company to scale diagnostic testing capabilities. Wheeler secures long-term financial stability through rigorous budget oversight and strategic resource management. The Chief Financial Officer collaborates with the board to align financial performance with the broader mission of delivering life-saving genetic tests. Through precise financial modeling, the Chief Financial Officer supports the expansion of the diagnostic portfolio, ensuring the company remains a leader in the molecular diagnostics industry while maintaining sustainable growth trajectories for all stakeholders.

Melissa Gonzales, the President, Women's Health, Myriad Genetics at Myriad Genetics, directs the strategic vision and commercial execution for the women's health diagnostic portfolio. Overseeing the development of specialized genetic tests, the President, Women's Health, Myriad Genetics ensures that clinical solutions address critical needs in reproductive and hereditary health. This leadership role involves managing the product lifecycle from research to market delivery, ensuring high standards of diagnostic accuracy. By expanding the reach of these tests, Melissa Gonzales directly impacts the quality of care for patients across the country. Gonzales coordinates with clinical partners and healthcare providers to integrate advanced diagnostics into standard medical practice. The President, Women's Health, Myriad Genetics drives revenue growth by identifying new market opportunities within the women's health sector. Through focused operational management, the President, Women's Health, Myriad Genetics ensures that the company remains at the forefront of providing actionable genetic insights for women's health.

Mark Verratti, the President at Myriad Genetics, directs the overarching operational strategy and execution of the company's molecular diagnostic mission. Overseeing the integration of business units, the President ensures that research, development, and commercial teams function as a cohesive entity. This leadership role involves setting the long-term strategic direction to maintain the company's status as a leader in the diagnostic industry. By optimizing operational efficiency, Mark Verratti directly impacts the speed and accuracy of test delivery to patients. Verratti manages the alignment of corporate goals with the needs of the healthcare market, ensuring that diagnostic innovations reach clinical settings effectively. The President collaborates with the board and other C-suite leaders to drive sustainable growth and market expansion. Through decisive leadership, the President ensures that the organization remains agile in the face of evolving medical technologies, ultimately supporting the company's commitment to improving patient health outcomes through advanced genetic testing.

Amy Sarola, the Legal & Compliance Operations Chief of Staff at Myriad Genetics, directs the integration of regulatory standards across all diagnostic service lines. Overseeing the internal governance framework, the Legal & Compliance Operations Chief of Staff ensures adherence to complex healthcare laws and data privacy requirements. This leadership role involves coordinating with cross-functional teams to mitigate operational risks while supporting the rapid deployment of new genetic tests. By streamlining compliance workflows, Amy Sarola directly impacts the efficiency of the legal department. Sarola manages the intersection of corporate policy and clinical research, ensuring that every diagnostic product meets stringent quality benchmarks. The Legal & Compliance Operations Chief of Staff facilitates communication between the executive team and regulatory bodies, maintaining the integrity of the company's market position. Through proactive risk assessment, the Legal & Compliance Operations Chief of Staff protects the intellectual property and operational continuity of the organization.

Shereen Solaiman, the Chief People Officer at Myriad Genetics, directs the talent acquisition and organizational development strategies necessary for a high-growth molecular diagnostics firm. Overseeing the human capital lifecycle, the Chief People Officer ensures the alignment of workforce capabilities with the evolving needs of the diagnostic industry. This leadership role involves fostering a culture of innovation and scientific excellence across all regional teams. By implementing comprehensive training programs, Shereen Solaiman directly impacts the retention of top-tier scientific and operational talent. Solaiman manages the strategic design of compensation and benefits to attract experts in molecular biology and clinical diagnostics. The Chief People Officer collaborates with the executive leadership to drive diversity and inclusion initiatives that strengthen the company's competitive advantage. Through data-driven workforce planning, the Chief People Officer supports the scaling of operations, ensuring the organization maintains the human expertise required to deliver accurate and timely genetic testing results.